Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Indivior Pharmaceuticals (INDV) EPS (Basic) (2024 - 2025)

Indivior Pharmaceuticals has reported EPS (Basic) over the past 2 years, most recently at $0.81 for Q4 2025.

  • Quarterly results put EPS (Basic) at $0.81 for Q4 2025, up 406.25% from a year ago — trailing twelve months through Dec 2025 was $1.68 (up 3260.0% YoY), and the annual figure for FY2025 was $1.68, up 3260.0%.
  • EPS (Basic) for Q4 2025 was $0.81 at Indivior Pharmaceuticals, up from $0.34 in the prior quarter.
  • Over the last five years, EPS (Basic) for INDV hit a ceiling of $0.81 in Q4 2025 and a floor of -$0.72 in Q2 2024.